(19)
(11) EP 2 190 817 A1

(12)

(43) Date of publication:
02.06.2010 Bulletin 2010/22

(21) Application number: 08787360.0

(22) Date of filing: 21.08.2008
(51) International Patent Classification (IPC): 
C07D 221/04(2006.01)
A61P 25/00(2006.01)
A61K 31/435(2006.01)
(86) International application number:
PCT/EP2008/060913
(87) International publication number:
WO 2009/027295 (05.03.2009 Gazette 2009/10)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated Extension States:
AL BA MK RS

(30) Priority: 24.08.2007 GB 0716633

(71) Applicant: Glaxo Group Limited
Greenford, Middlesex UB6 0NN (GB)

(72) Inventors:
  • BERTANI, Barbara
    I-37135 Verona (IT)
  • BONANOMI, Giorgio
    I-37135 Verona (IT)
  • DI FABIO, Romano
    I-37135 Verona (IT)
  • FAZZOLARI, Elettra
    I-37135 Verona (IT)
  • MICHELI, Fabrizio
    I-37135 Verona (IT)
  • TARSI, Luca
    I-37135 Verona (IT)

(74) Representative: Sewell, Richard Charles 
GlaxoSmithKline (CN925.1), 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

   


(54) 3-AZABICYCLO (4.1.0) HEPTANE DERIVATIVES USEFUL AS NOREPINEPHRINE, SEROTONIN OR DOPAMINE REUPTAKE INHIBITORS